Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes.: A single-blind, randomized, controlled, cros-over trial

Emilie Bundgaard Lindkvist; Christian Laugesen; Asbjørn Thode Reenberg; Tobias K.S. Ritschel; Jannet Svensson; J Jørgensen; Ajenthen  Ranjan; Kirsten Nørgaard

doi:10.1089/dia.2023.2525.abstracts

Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes. A single-blind, randomized, controlled, cros-over trial

Emilie Bundgaard Lindkvist, Christian Laugesen, Asbjørn Thode Reenberg, Tobias K.S. Ritschel, Jannet Svensson, J Jørgensen, Ajenthen Ranjan, Kirsten Nørgaard

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Artikelnummer	771
Tidsskrift	Diabetes Technology and Therapeutics
Vol/bind	25
Udgave nummer	S2
ISSN	1520-9156
DOI	https://doi.org/10.1089/dia.2023.2525.abstracts
Status	Udgivet - 21 feb. 2023
Begivenhed	ATTD 2023 16th International Conference on Advanced Technologies & Treatments for Diabetes - Berlin, Berlin, Tyskland Varighed: 22 feb. 2023 → 25 feb. 2023 Konferencens nummer: 16 https://attd2023.kenes.com/

Konference

Konference	ATTD 2023 16th International Conference on Advanced Technologies & Treatments for Diabetes
Nummer	16
Lokation	Berlin
Land/Område	Tyskland
By	Berlin
Periode	22/02/2023 → 25/02/2023
Internetadresse	https://attd2023.kenes.com/

Adgang til dokumentet

10.1089/dia.2023.2525.abstracts

Citationsformater

Lindkvist, E. B., Laugesen, C., Reenberg, A. T., Ritschel, T. K. S., Svensson, J., Jørgensen, J., Ranjan, A., & Nørgaard, K. (2023). Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes. A single-blind, randomized, controlled, cros-over trial. Diabetes Technology and Therapeutics, 25(S2), Artikel 771. https://doi.org/10.1089/dia.2023.2525.abstracts

Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes. A single-blind, randomized, controlled, cros-over trial. / Lindkvist, Emilie Bundgaard; Laugesen, Christian; Reenberg, Asbjørn Thode et al.
I: Diabetes Technology and Therapeutics, Bind 25, Nr. S2, 771, 21.02.2023.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Lindkvist, EB, Laugesen, C, Reenberg, AT, Ritschel, TKS, Svensson, J, Jørgensen, J, Ranjan, A & Nørgaard, K 2023, 'Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes. A single-blind, randomized, controlled, cros-over trial', Diabetes Technology and Therapeutics, bind 25, nr. S2, 771. https://doi.org/10.1089/dia.2023.2525.abstracts

@article{ccfab25d723e46f784d7c9e473da8e4c,

title = "Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes.: A single-blind, randomized, controlled, cros-over trial",

author = "Lindkvist, {Emilie Bundgaard} and Christian Laugesen and Reenberg, {Asbj{\o}rn Thode} and Ritschel, {Tobias K.S.} and Jannet Svensson and J J{\o}rgensen and Ajenthen Ranjan and Kirsten N{\o}rgaard",

year = "2023",

month = feb,

day = "21",

doi = "10.1089/dia.2023.2525.abstracts",

language = "English",

volume = "25",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann/Liebert, Inc. Publishers",

number = "S2",

note = "ATTD 2023 16th International Conference on Advanced Technologies & Treatments for Diabetes, ATTD ; Conference date: 22-02-2023 Through 25-02-2023",

url = "https://attd2023.kenes.com/",

}

TY - ABST

T1 - Performance of a dual-hormone closed-loop system versus insulin-only closed-loop in adolescents with type 1 diabetes.

T2 - ATTD 2023 16th International Conference on Advanced Technologies & Treatments for Diabetes

AU - Lindkvist, Emilie Bundgaard

AU - Laugesen, Christian

AU - Reenberg, Asbjørn Thode

AU - Ritschel, Tobias K.S.

AU - Svensson, Jannet

AU - Jørgensen, J

AU - Ranjan, Ajenthen

AU - Nørgaard, Kirsten

N1 - Conference code: 16

PY - 2023/2/21

Y1 - 2023/2/21

U2 - 10.1089/dia.2023.2525.abstracts

DO - 10.1089/dia.2023.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 25

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - S2

M1 - 771

Y2 - 22 February 2023 through 25 February 2023

ER -